Application Nr Approved Date Route Status External Links
NDA021536 None Subcutaneous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Levemir Is Indicated To Improve Glycemic Control In Adults And Children With Diabetes Mellitus. Important Limitations Of Use: • Levemir Is Not Recommended For The Treatment Of Diabetic Ketoacidosis. Intravenous Rapid-Acting Or Short-Acting Insulin Is The Preferred Treatment For This Condition. Levemir Is A Long-Acting Human Insulin Analog Indicated To Improve Glycemic Control In Adults And Children With Diabetes Mellitus ( 1 ). Important Limitations Of Use: • Not Recommended For Treating Diabetic Ketoacidosis. Use Intravenous, Rapid-Acting Or Short-Acting Insulin Instead.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Insulin Detemir

Comments